Underestimated Prediabetic Biomarkers: Are We Blind to Their Strategy?

Type 2 Diabetes (T2D) is currently one of the fastest growing health challenging, a non-communicable disease result of the XXI century lifestyle. Given its growing incidence and prevalence, it became increasingly imperative to develop new technologies and implement new biomarkers for early diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Luís, Carla, Soares, Raquel, Baylina, Pilar, Fernandes, Rúben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936175/
https://www.ncbi.nlm.nih.gov/pubmed/35321333
http://dx.doi.org/10.3389/fendo.2022.805837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936175/
https://www.ncbi.nlm.nih.gov/pubmed/35321333
http://dx.doi.org/10.3389/fendo.2022.805837

Ejemplares similares